• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WW 结构域结合蛋白 2 的过表达通过 AMPKβ1 防止饮食诱导的肝脂肪变性和胰岛素抵抗。

WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.

机构信息

Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Cell Death Dis. 2021 Mar 3;12(3):228. doi: 10.1038/s41419-021-03536-8.

DOI:10.1038/s41419-021-03536-8
PMID:33658485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7930037/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is prevalent clinically and can lead to more serious chronic liver disease. However, the pathological mechanism is still unclear, and thus, there are no approved drugs on the market. Transcriptional coactivator WW domain-binding protein 2 (WBP2) is a newly discovered oncogene that has an important relationship with the occurrence and development of breast cancer and mediates the interaction between Wnt and various other signaling pathways. The expression level of WBP2 was decreased in NAFLD. Overexpression of WBP2 with AAV in vivo alleviated liver fat deposition and insulin resistance induced by a high-fat diet (HFD). Knockdown of WBP2 with AAV aggravated HFD-induced fatty liver and insulin resistance. In vitro experiments showed that in the human normal hepatocyte cell line LO2 and primary hepatocytes isolated from mice, overexpression of WBP2 reduced fat deposition, and knocking out or knocking down WBP2 aggravated PA-induced fat deposition. Through mass spectrometry, we found that WBP2 can bind to AMPKβ1, and by mutating AMPKβ1, we found that WBP2 can induce phosphorylation of AMPKβ1 at S108 and then activate the AMPK pathway to affect lipid metabolism. The effect of WBP2 on NAFLD provides a possible new direction for future research on NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)在临床上较为常见,可导致更严重的慢性肝病。然而,其病理机制尚不清楚,因此市场上尚无批准的药物。转录共激活因子 WW 结构域结合蛋白 2(WBP2)是一种新发现的癌基因,与乳腺癌的发生发展有重要关系,并介导 Wnt 与各种其他信号通路的相互作用。WBP2 的表达水平在 NAFLD 中降低。体内用 AAV 过表达 WBP2 可减轻高脂肪饮食(HFD)引起的肝脂肪沉积和胰岛素抵抗。用 AAV 敲低 WBP2 可加重 HFD 诱导的脂肪肝和胰岛素抵抗。体外实验表明,在人正常肝细胞系 LO2 和从小鼠分离的原代肝细胞中,过表达 WBP2 可减少脂肪沉积,敲除或敲低 WBP2 可加重 PA 诱导的脂肪沉积。通过质谱分析,我们发现 WBP2 可以与 AMPKβ1 结合,通过突变 AMPKβ1,我们发现 WBP2 可以诱导 AMPKβ1 的 S108 磷酸化,从而激活 AMPK 通路,影响脂质代谢。WBP2 对 NAFLD 的作用为 NAFLD 的未来研究提供了一个可能的新方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/775124802293/41419_2021_3536_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/176db88abd8f/41419_2021_3536_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/b753f9038bb7/41419_2021_3536_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/448a9e0edd86/41419_2021_3536_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/af2322bfbd91/41419_2021_3536_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/bd7d0221526e/41419_2021_3536_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/b97139c9921a/41419_2021_3536_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/5b2b92928d1f/41419_2021_3536_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/775124802293/41419_2021_3536_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/176db88abd8f/41419_2021_3536_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/b753f9038bb7/41419_2021_3536_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/448a9e0edd86/41419_2021_3536_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/af2322bfbd91/41419_2021_3536_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/bd7d0221526e/41419_2021_3536_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/b97139c9921a/41419_2021_3536_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/5b2b92928d1f/41419_2021_3536_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c372/7930037/775124802293/41419_2021_3536_Fig8_HTML.jpg

相似文献

1
WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.WW 结构域结合蛋白 2 的过表达通过 AMPKβ1 防止饮食诱导的肝脂肪变性和胰岛素抵抗。
Cell Death Dis. 2021 Mar 3;12(3):228. doi: 10.1038/s41419-021-03536-8.
2
GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.GCSF 缺乏通过调节 GCSFR-SOCS3-JAK-STAT3 通路和免疫细胞浸润来减轻非酒精性脂肪性肝病。
Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G531-G542. doi: 10.1152/ajpgi.00342.2020. Epub 2021 Jan 20.
3
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.通过胰高血糖素依赖途径,KCTD17介导的PHLPP2降解促进肝脂肪变性。
Gastroenterology. 2017 Dec;153(6):1568-1580.e10. doi: 10.1053/j.gastro.2017.08.039. Epub 2017 Aug 30.
4
IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.IGFBP5 通过激活 AMPK 通路在非酒精性脂肪肝病中调节脂代谢和胰岛素敏感性。
Life Sci. 2020 Sep 1;256:117997. doi: 10.1016/j.lfs.2020.117997. Epub 2020 Jun 22.
5
Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.环状 RNA 0057558 通过靶向 miR-206 调控 ROCK1/AMPK 信号通路促进非酒精性脂肪性肝病。
Cell Death Dis. 2021 Aug 26;12(9):809. doi: 10.1038/s41419-021-04090-z.
6
Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.益母草水提物通过抑制游离脂肪酸诱导的 HepG2 细胞和高脂饮食喂养小鼠的非酒精性脂肪肝病。
Nutrients. 2017 Dec 25;10(1):20. doi: 10.3390/nu10010020.
7
LB100 ameliorates nonalcoholic fatty liver disease the AMPK/Sirt1 pathway.LB100 通过 AMPK/Sirt1 通路改善非酒精性脂肪性肝病。
World J Gastroenterol. 2019 Dec 7;25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607.
8
Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.莲心碱通过调节TAK1/AMPK信号通路抑制氧化应激和炎症,从而减轻高脂饮食(HFD)诱导的非酒精性脂肪性肝病(NAFLD)。
Int Immunopharmacol. 2022 Mar;104:108306. doi: 10.1016/j.intimp.2021.108306. Epub 2022 Jan 6.
9
Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.维生素 D 受体靶向肝细胞核因子 4α 并介导维生素 D 在非酒精性脂肪性肝病中的保护作用。
J Biol Chem. 2020 Mar 20;295(12):3891-3905. doi: 10.1074/jbc.RA119.011487. Epub 2020 Feb 12.
10
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.漆黄素通过调节高脂肪饮食诱导的肥胖小鼠中的Sirt1/AMPK和脂肪酸β-氧化信号通路来预防肝脂肪变性。
Cell Physiol Biochem. 2018;49(5):1870-1884. doi: 10.1159/000493650. Epub 2018 Sep 20.

引用本文的文献

1
Multi-Ancestry Transcriptome-Wide Association Studies of Cognitive Function, White Matter Hyperintensity, and Alzheimer's Disease.认知功能、脑白质高信号和阿尔茨海默病的多祖先全转录组关联研究
Int J Mol Sci. 2025 Mar 9;26(6):2443. doi: 10.3390/ijms26062443.
2
Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver disease.肝脏雌激素受体α驱动绝经后患有代谢功能障碍相关脂肪性肝病的女性男性化。
JHEP Rep. 2024 Jun 13;6(10):101143. doi: 10.1016/j.jhepr.2024.101143. eCollection 2024 Oct.
3
Hepatic Dyrk1b impairs systemic glucose homeostasis by modulating Wbp2 expression in a kinase activity-dependent manner.

本文引用的文献

1
Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.葛根素通过激活 AdipoR1/2 通路改善血管内皮功能障碍来减轻糖尿病肾病。
Pharmacol Res. 2020 Mar;153:104678. doi: 10.1016/j.phrs.2020.104678. Epub 2020 Jan 31.
2
AMP-activated protein kinase complexes containing the β2 regulatory subunit are up-regulated during and contribute to adipogenesis.AMP 激活的蛋白激酶复合物包含β2 调节亚基,在脂肪生成过程中被上调,并对其有贡献。
Biochem J. 2019 Jun 26;476(12):1725-1740. doi: 10.1042/BCJ20180714.
3
Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease.
肝脏中的双重特异性酪氨酸磷酸化调节激酶1B(Dyrk1b)通过以激酶活性依赖的方式调节Wbp2的表达来损害全身葡萄糖稳态。
Heliyon. 2024 Aug 22;10(17):e36726. doi: 10.1016/j.heliyon.2024.e36726. eCollection 2024 Sep 15.
4
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease.磷酸化:脂肪性肝病发病机制和治疗的新靶点。
Lipids Health Dis. 2024 Feb 17;23(1):50. doi: 10.1186/s12944-024-02037-9.
5
Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics.多组学揭示的肾脏代偿性肥大中的信号机制。
Nat Commun. 2023 Jun 16;14(1):3481. doi: 10.1038/s41467-023-38958-9.
6
WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review.WW结构域结合蛋白2(WBP2)作为乳腺癌中的一种癌基因:作用机制与治疗前景——一篇叙述性综述
Gland Surg. 2022 Dec;11(12):1984-2002. doi: 10.21037/gs-22-716.
7
Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病和肝细胞癌共同致病基因的筛查
Front Oncol. 2022 Aug 11;12:911808. doi: 10.3389/fonc.2022.911808. eCollection 2022.
免疫系统的变化——非酒精性脂肪性肝病患者诊断与治疗的关键
Cent Eur J Immunol. 2018;43(2):231-239. doi: 10.5114/ceji.2018.77395. Epub 2018 Jun 30.
4
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.隐源性肝硬化(CC)和非酒精性脂肪性肝炎(NASH)肝硬化的肝移植(LT):来自移植受者科学登记处(SRTR)的数据:1994年至2016年。
Medicine (Baltimore). 2018 Aug;97(31):e11518. doi: 10.1097/MD.0000000000011518.
5
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
6
WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.WW结构域结合蛋白2:一种与乳腺癌发展密切相关的衔接蛋白。
Mol Cancer. 2017 Jul 19;16(1):128. doi: 10.1186/s12943-017-0693-9.
7
AMPK signalling in health and disease.健康与疾病中的AMPK信号传导。
Curr Opin Cell Biol. 2017 Apr;45:31-37. doi: 10.1016/j.ceb.2017.01.005. Epub 2017 Feb 21.
8
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.30年的核因子κB研究:与人类病理生物学的关联蓬勃发展
Cell. 2017 Jan 12;168(1-2):37-57. doi: 10.1016/j.cell.2016.12.012.
9
PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.PARP1介导的PPARα多聚(ADP - 核糖基)化抑制非酒精性脂肪性肝病中的脂肪酸氧化。
J Hepatol. 2017 May;66(5):962-977. doi: 10.1016/j.jhep.2016.11.020. Epub 2016 Dec 12.
10
Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2.Wnt 信号通过阻止 ITCH 介导的 YAP/TAZ 转录共激活因子 WBP2 的降解促进乳腺癌发生。
Cancer Res. 2016 Nov 1;76(21):6278-6289. doi: 10.1158/0008-5472.CAN-15-3537. Epub 2016 Aug 30.